199 related articles for article (PubMed ID: 18473730)
1. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.
Bacolod MD; Lin SM; Johnson SP; Bullock NS; Colvin M; Bigner DD; Friedman HS
Curr Cancer Drug Targets; 2008 May; 8(3):172-9. PubMed ID: 18473730
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide resistance in medulloblastoma.
Friedman HS; Colvin OM; Kaufmann SH; Ludeman SM; Bullock N; Bigner DD; Griffith OW
Cancer Res; 1992 Oct; 52(19):5373-8. PubMed ID: 1356617
[TBL] [Abstract][Full Text] [Related]
3. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.
Dong Q; Bullock N; Ali-Osman F; Colvin OM; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1996; 37(3):242-46. PubMed ID: 8529284
[TBL] [Abstract][Full Text] [Related]
4. Busulfan therapy of central nervous system xenografts in athymic mice.
Aaron RH; Elion GB; Colvin OM; Graham M; Keir S; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1994; 35(2):127-31. PubMed ID: 7987988
[TBL] [Abstract][Full Text] [Related]
5. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Cowman S; Fan YN; Pizer B; Sée V
BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
Friedman HS; Pegg AE; Johnson SP; Loktionova NA; Dolan ME; Modrich P; Moschel RC; Struck R; Brent TP; Ludeman S; Bullock N; Kilborn C; Keir S; Dong Q; Bigner DD; Colvin OM
Cancer Chemother Pharmacol; 1999; 43(1):80-5. PubMed ID: 9923545
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms of cyclophosphamide resistance: model studies in human medulloblastoma cell lines.
Friedman HS; Johnson SP; Colvin OM
Cancer Treat Res; 2002; 112():199-209. PubMed ID: 12481718
[No Abstract] [Full Text] [Related]
8. Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).
Dong Q; Johnson SP; Colvin OM; Bullock N; Kilborn C; Runyon G; Sullivan DM; Easton J; Bigner DD; Nahta R; Marks J; Modrich P; Friedman HS
Cancer Chemother Pharmacol; 1999; 43(1):73-9. PubMed ID: 9923544
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
Tsukamoto N; Chen J; Yoshida A
Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
11. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine.
Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG
Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672
[TBL] [Abstract][Full Text] [Related]
12. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis.
Narendra G; Raju B; Verma H; Silakari O
Med Oncol; 2021 Sep; 38(10):123. PubMed ID: 34491453
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of human erythrocyte aldehyde dehydrogenase to the systemic detoxification of the oxazaphosphorines.
Dockham PA; Sreerama L; Sladek NE
Drug Metab Dispos; 1997 Dec; 25(12):1436-41. PubMed ID: 9394035
[TBL] [Abstract][Full Text] [Related]
16. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase.
Bunting KD; Lindahl R; Townsend AJ
J Biol Chem; 1994 Sep; 269(37):23197-203. PubMed ID: 8083225
[TBL] [Abstract][Full Text] [Related]
17. Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines.
He XM; Ostrowski LE; von Wronski MA; Friedman HS; Wikstrand CJ; Bigner SH; Rasheed A; Batra SK; Mitra S; Brent TP
Cancer Res; 1992 Mar; 52(5):1144-8. PubMed ID: 1737373
[TBL] [Abstract][Full Text] [Related]
18. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.
Zhang G; Ma L; Xie YK; Miao XB; Jin C
Mol Med Rep; 2012 Sep; 6(3):519-24. PubMed ID: 22684859
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle gene expression in lovastatin-induced medulloblastoma apoptosis.
Wang W; Macaulay RJ
Can J Neurol Sci; 2003 Nov; 30(4):349-57. PubMed ID: 14672267
[TBL] [Abstract][Full Text] [Related]
20. Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization.
Heibein AD; Guo B; Sprowl JA; Maclean DA; Parissenti AM
BMC Cancer; 2012 Aug; 12():381. PubMed ID: 22938713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]